About Rexer Pharma Private Limited
Data last updated:
Rexer Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 December 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1996PTC026005. Its GSTIN is 36AAACR9920K1Z2 (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors including Sujana Seelam and Madallapalli Surya Mohan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 114/2/B Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.9 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹73,139 (net margin 0.3%) and EBITDA of ₹5.34 Lakh (EBITDA margin 1.8%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 1% over five years.
The company has about 16 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Rexer Pharma. As per MCA filings, the company has satisfied charges of ₹1.51 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rexerpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address114/2/B Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Rexer Pharma Private Limited
The main business activity of Rexer Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rexer Pharma Private Limited FY 2025 filings available
Rexer Pharma Private Limited reported revenue of ₹2.9 Cr (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Rexer Pharma Private Limited
Revenue rose 5% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rexer Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.34 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹73,139 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rexer Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rexer Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Rexer Pharma Private Limited
Rexer Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fastag Formulations Private Limited | ₹2.92 Cr (FY 2022) | •••• | •••• | 64.0% | •••• | Varanasi, Uttar Pradesh, India |
| Taxane Healthcare Private Limited | ₹2.92 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Ahmedabad, Gujarat, India |
| Saha Biological Pvt Ltd | ₹2.92 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Kolkata, West Bengal, India |
| Andwin Pharma Private Limited | ₹2.91 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Bangalore, Karnataka, India |
| Epcure Pharmalab Private Limited | ₹2.91 Cr (FY 2022) | •••• | •••• | 5801.0% | •••• | Indore, Madhya Pradesh, India |
| Rexer Pharma Private Limited this company | ₹2.9 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Hyderabad, Telangana, India |
| Blue Mountain Pharmaceutical Industries Private Limited | ₹2.9 Cr (FY 2025) | •••• | •••• | 640.0% | •••• | Thoothukudi, Tamil Nadu, India |
| Trio Remedies Pvt Ltd | ₹2.9 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Ahmedabad, Gujarat, India |
| Almatica Pharmaceuticals Private Limited | ₹2.89 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Panchkula, Haryana, India |
| Eruca Healthcare Private Limited | ₹2.88 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Mumbai, Maharashtra, India |
| Dr. Dubes Health Care Private Limited | ₹2.87 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Rexer Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rexer Pharma Private Limited
Rexer Pharma Private Limited is audited by K . SIVARAMAIAH for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K . SIVARAMAIAH | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Rexer Pharma Private Limited
Rexer Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujana Seelam | Director | 23 Jan 2017 | 9 Years 8 Months | Current |
| Madallapalli Surya Mohan | Director | 20 Dec 1996 | 29 Years 9 Months | Current |
| Raghava Reddy Gureddygari | Director | 20 Dec 1996 | 29 Years 9 Months | Current |
Ownership and Shareholding of Rexer Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rexer Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 2016 | Others | ₹15 Lakh | Satisfied |
| 30 Mar 2010 | Andhra Pradesh State Financial Corporation | ₹40 Lakh | Satisfied |
| 20 Jul 2007 | Others | ₹20 Lakh | Satisfied |
| 18 Mar 2005 | A. P. State Financial Corporation | ₹76 Lakh | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Rexer Pharma Private Limited
Rexer Pharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, HAVERI, Karnataka | Criminal miscellaneous application | Filed against the company by an individual | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Rexer Pharma Private Limited
Rexer Pharma Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 46 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Dots Lifescience Private Limited | •••• | •••• | •••• |
| Rashmi Pharma Private Limited | •••• | •••• | •••• |
| Esjay Poly Products Pvt Ltd | •••• | •••• | •••• |
| Serin Formulations Private Limited | •••• | •••• | •••• |
| Sri Venkateshwara Coil Mill Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Rexer Pharma Private Limited
Rexer Pharma operates one associated brand: Rexer Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports pharmaceutical formulations, antibiotics, injectables, and anti-inflammatory drugs worldwide. | rexerpharma.com |
Employees and EPFO Compliance at Rexer Pharma Private Limited
Rexer Pharma Private Limited has a workforce of 16 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Rexer Pharma Private Limited
Rexer Pharma has one previous CIN (Corporate Identification Number): U24230AP1996PTC026005. The current CIN is U24230TG1996PTC026005, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1996PTC026005 | Current |
| U24230AP1996PTC026005 | Previous |
Recent Activity on Rexer Pharma Private Limited
Rexer Pharma Private Limited has 5 board changes on record since 1996: 4 appointments and 1 cessation. The latest: Sujana Seelam was appointed as Director on 23 Jan 2017.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Rexer Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rexer Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rexer Pharma Private Limited
Rexer Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACR9920K1Z2 | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rexer Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rexer Pharma Private Limited
Rexer Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 December 1996 (30+ years old) and is registered under CIN U24230TG1996PTC026005.
Rexer Pharma reported revenue of ₹2.9 Cr for FY 2024 (up 5% YoY).
Rexer Pharma has 3 current directors:
- Sujana Seelam - Director
- Madallapalli Surya Mohan - Director
- Raghava Reddy Gureddygari - Director
Rexer Pharma reported a net profit of ₹73,139 (net margin 0.3%) and EBITDA of ₹5.34 Lakh (EBITDA margin 1.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rexer Pharma is 9% over three years and -1% over five years. In the latest year (FY 2024) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rexer Pharma is 36AAACR9920K1Z2, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Rexer Pharma is U24230TG1996PTC026005. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rexer Pharma has 1 court case on record: 1 filed against it.
Rexer Pharma was incorporated on 20 December 1996, making it 30+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Rexer Pharma by revenue are Fastag Formulations Private Limited, Taxane Healthcare Private Limited, Saha Biological Pvt Ltd, Andwin Pharma Private Limited, Epcure Pharmalab Private Limited and 5 more, all in the Pharma industry (Formulations).
Sujana Seelam was appointed as Director on 23 Jan 2017. Seelam Sreenivas Reddy ceased to be Director on 29 Jul 2016. Madallapalli Surya Mohan was appointed as Director on 20 Dec 1996. Rexer Pharma has 5 board changes on record in total.
Rexer Pharma has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 46 overdue payments to 5 micro and small suppliers. The latest return was filed on 08 Jun 2019.